Status: Recruiting
PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
The aim of this study is to evaluate the safety of prasugrel monotherapy without aspirin versus 12-month dual antiplatelet therapy (DAPT) in patients with STEMI using platinum-chrome everolimus-eluting stent (PtCr-EES: SYNERGYTM).
Participants needed: 2,258
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Kindai UniversityUpdated: Mar 1, 2023Locations: 1
Eligibility criteria
Patients scheduled for primary PCI with everolimus-eluting stent (PtCr-EES, SYNE... [+2]
Patients taking anticoagulants [+3]